Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases-Reference-Cited by-同舟云学术

Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases

Published:2013-02-22 Issue:2 Volume:345 Page:260-270
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Salmon Michael,Luttmann Mark A.,Foley James J.,Buckley Peter T.,Schmidt Dulcie B.,Burman Miriam,Webb Edward F.,DeHaas Christopher J.,Kotzer Charles J.,Barrett Victoria J.,Slack Robert J.,Sarau Henry M.,Palovich Michael R.,Lainé Dramane I.,Hay Douglas W. P.,Rumsey William L.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference37 articles.

1. Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor

2. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

3. Tiotropium bromide

4. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes

5. Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023;Lung;2024-02-06

2. Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study;International Journal of Chronic Obstructive Pulmonary Disease;2023-05

3. Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan;Frontiers in Physiology;2023-04-21

4. Multitargeting nature of muscarinic orthosteric agonists and antagonists;Frontiers in Physiology;2022-09-06

5. Optimizing asthma management: Role of long-acting muscarinic antagonists;Journal of Allergy and Clinical Immunology;2022-09